Nia Therapeutics announced the publication of the first in vivo validation of its wireless, implantable brain-computer ...

Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation ...

For decades, neurology treated the brain like a black box, nudging it with drugs and hoping symptoms would ease. Now ...

Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its commercial rollout with its first procedures. At the same time, the medtech ...

Each year when MD+DI editors sit down to discuss Medtech Company of the Year prospects, the companies that rise to the top for us tend to be those that have had a transformational year either through ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...

[SINGAPORE] Shares of two local banks, DBS and OCBC, hit all-time highs on Tuesday (Dec 16), while UOB trailed its peers. Singapore’s largest lender, DBS, reached a new record of S$56 at 9.07 am, up ...

Neurostimulation devices market was valued at US$ 9.84 billion in 2024 and is projected to hit the market valuation of US$ 22.64 billion by 2033 at a CAGR of 9.7% during the forecast period 2025–2033.

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

Scientists sought to better understand how humans evolved to become so skilled at thinking about what's happening in other peoples' minds. The findings could have implications for one day treating ...